| 6315 |
Centers for Disease Control and Prevention |
Html |
en |
CDC reports excessive alcohol consumption cost the U.S. $224 billion in 2006 - Press Release: October 17, 2011 |
CDC reports excessive alcohol consumption cost the U.S. $224 billion in 2006 |
| excessive drinking cost | 0.499574 |
| daily alcohol consumption | 0.41114 |
| enormous costs | 0.277484 |
| total economic costs | 0.325705 |
| Lewin Group | 0.311331 |
| pregnant women | 0.259756 |
| CDC Director Thomas | 0.315462 |
| criminal justice systems. | 0.305002 |
| burdensome cost | 0.274303 |
| lower household income | 0.289974 |
| binge spending | 0.289891 |
| new study | 0.274411 |
| Disease Impact Application | 0.303942 |
| health care system. | 0.319062 |
| National Epidemiologic Survey | 0.306711 |
| Health web site | 0.311506 |
| heavy drinking | 0.315841 |
| binge drinking | 0.404449 |
| alcoholic beverage | 0.264363 |
| effective public health | 0.309665 |
| criminal justice | 0.314593 |
| excessive drinker | 0.382663 |
| United States | 0.435094 |
| private health care | 0.322036 |
|
| underage youth | 0.261448 |
| behavioral health issues | 0.313565 |
| previous study | 0.264743 |
| alcoholic beverages | 0.32653 |
| percent | 0.304811 |
| United States. | 0.26202 |
| alcohol misuse | 0.327881 |
| Robert Wood Johnson | 0.292214 |
| excessive drinkers | 0.37084 |
| Disease Control | 0.264143 |
| Alcohol Program Leader | 0.36296 |
| excessive drinking | 0.594432 |
| landmark study | 0.262378 |
| total cost | 0.366221 |
| substance abuse | 0.306207 |
| health care expenses | 0.41061 |
| vehicle crash costs | 0.329317 |
| law enforcement | 0.258984 |
| Pamela S. Hyde | 0.298568 |
| alcohol consumption inflicts | 0.425407 |
| cost estimate | 0.273695 |
| R. Frieden | 0.260581 |
| Mental Health Services | 0.31709 |
| criminal justice expenses | 0.314273 |
|
CLICK HERE |
| 7340 |
Centers for Disease Control and Prevention |
Html |
en |
H3N2v Treatment |
H3N2v Treatment - CDC |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7506 |
Centers for Disease Control and Prevention |
Html |
en |
Healthy Housing Reference Manual - Abbreviations and Acronyms |
NCEH provides leadership to promote health and quality of life by preventing or controlling those diseases, birth defects, or disabilities resulting from interaction between people and the environment. Site has information/education resources on a broad range of topics, including asthma, birth defects, radiation, sanitation, lead in blood, and more. |
|
|
CLICK HERE |
| 7623 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccines: Smallpox Vaccination |
Smallpox vaccine info for parents, public, and healthcare professionals |
| VPD-VAC/Smallpox/main page | 0.62911 |
|
|
CLICK HERE |
| 8096 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Zinc Deficiency Dermatitis inCholestatic Extremely Premature Infants After a Nationwide Shortageof Injectable Zinc - Washington, DC, December 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.401171 |
| zinc deficiency dermatitis | 0.821826 |
| Human Services | 0.440826 |
| assistive technology | 0.397439 |
| MMWR HTML versions | 0.451596 |
| U.S. Department | 0.440385 |
| zinc supplementation | 0.681203 |
| perioral erosions | 0.470599 |
| low albumin binding | 0.456434 |
| electronic PDF version | 0.451224 |
| poor wound healing | 0.451872 |
| negligible tissue stores | 0.449643 |
| intensive care unit | 0.608805 |
| insufficient zinc | 0.603694 |
| zinc levels | 0.595395 |
| Wanda D. Barfield | 0.454412 |
| urinary zinc losses | 0.654167 |
| Fetal zinc accumulation | 0.658653 |
| Inadequate zinc supplementation | 0.664943 |
| shows zinc deficiency | 0.647407 |
| original paper copy | 0.445113 |
| nationwide shortage | 0.48112 |
| National Medical Center | 0.452444 |
| dorsal surfaces | 0.47771 |
|
| original MMWR paper | 0.457945 |
| U.S. Government Printing | 0.455091 |
| injectable zinc supplements | 0.717746 |
| injectable zinc | 0.856271 |
| Skin biopsy specimens | 0.460719 |
| trace element toxicity | 0.459469 |
| parenteral trace elements | 0.485498 |
| parenteral nutrition | 0.411528 |
| Scott A. Norton | 0.564247 |
| neonatal intensive care | 0.612438 |
| zinc chloride | 0.581761 |
| PN pharmacy | 0.420306 |
| subject line | 0.398574 |
| plasma zinc | 0.592363 |
| zinc sulfate | 0.583915 |
| severe cholestasis | 0.417912 |
| Chronic Disease Prevention | 0.444751 |
| skin lesions | 0.461474 |
| erosive lesions | 0.398525 |
| diaper region | 0.477583 |
| trace element products | 0.451847 |
| cholestatic infants | 0.596646 |
| NICUs caring | 0.397018 |
| extremely premature infants | 0.907201 |
|
CLICK HERE |
| 9270 |
Centers for Disease Control and Prevention |
Html |
es |
Preventing Chronic Disease - CDC: Volume 10, 2013: 12_0301 |
Volumen 10 — el 30 de mayo de 2013. |
|
|
CLICK HERE |
| 11785 |
Centers for Disease Control and Prevention |
Video |
en |
CDC update on Dallas Ebola Response, 10-12-2014 |
CDC hosts a media briefing to provide an update on Dallas Ebola Response
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at http://streaming.cdc.gov/vod.php?id=7e67d2439dfc5d4db93478250ffdbcd720141015084557215 |
| CDC Media Briefing | 0.912307 |
|
| Dallas Ebola Response | 0.720342 |
|
CLICK HERE |
| 13539 |
Centers for Disease Control and Prevention |
Html |
en |
Using Social Network Analysis to Assess Mentorship andCollaboration in a Public Health Network |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| mentorship network | 0.248365 |
| mentorship | 0.592401 |
| collaborative networks | 0.269938 |
| collaboration networks | 0.378841 |
| HAN member | 0.296673 |
| healthy aging research | 0.460758 |
| network | 0.565816 |
| HAN mentorship | 0.452625 |
| ties | 0.295916 |
| Aging Research Network | 0.384281 |
| product collaboration ties | 0.201224 |
| HAN member organizations | 0.288522 |
| collaboration relationships | 0.326083 |
|
| CDC HAN | 0.221837 |
| public health | 0.262749 |
| HAN members | 0.921976 |
| actors | 0.248648 |
| collaboration ties | 0.215058 |
| mentorship ties | 0.278217 |
| Research Network members | 0.239897 |
| partners | 0.222937 |
| cohesive collaboration network | 0.206466 |
| collaboration | 0.533472 |
| chronic disease | 0.211752 |
| HAN coordinating center | 0.210886 |
| member centers | 0.353435 |
|
CLICK HERE |
| 13786 |
Centers for Disease Control and Prevention |
Html |
null |
Vaccines: Meningococcal Vaccination |
Meningococcal vaccine info for parents, public, and healthcare professionals |
|
|
CLICK HERE |
| 14465 |
Centers for Disease Control and Prevention |
Html |
en |
Protocols | Million Hearts |
Create your own or adopt and use standardized treatment protocols for improving blood pressure control. |
| major risk factor | 0.701059 |
| tobacco user | 0.677626 |
| featured evidence-based protocols | 0.74585 |
| dyslipidemia addresses treatment | 0.713519 |
| major statin benefit | 0.675069 |
| new clinical guidelines | 0.692492 |
| integrated health care | 0.696011 |
| primary care providers | 0.693901 |
| tobacco cessation protocol | 0.794937 |
| ASCVD Risk Estimator | 0.729089 |
| tobacco cessation | 0.92644 |
| ascvd risk | 0.863429 |
| ASCVD risk estimates | 0.724899 |
| cholesterol management protocol | 0.721906 |
| National Dyslipidemia Management | 0.692504 |
| tobacco cessation treatment | 0.798462 |
| style case study | 0.758005 |
| health care providers | 0.702711 |
| hypertension treatment protocol | 0.686826 |
| health care professionals | 0.775218 |
| cardiovascular disease risk | 0.69714 |
| patients | 0.716049 |
| lifetime ASCVD risk | 0.725946 |
| primary care physicians | 0.689686 |
|
| 10-year ASCVD risk | 0.73972 |
| tobacco dependence treatment | 0.881537 |
| tobacco intervention workflow | 0.73465 |
| VHA smoking cessation | 0.674327 |
| evidence-based protocols | 0.873399 |
| tobacco use identification | 0.676288 |
| Tobacco cessation protocols | 0.824886 |
| health professional students | 0.67656 |
| atherosclerotic cardiovascular disease | 0.685357 |
| question-and-answer style case | 0.760851 |
| health delivery systems | 0.687338 |
| extensive health systems | 0.688475 |
| tobacco cessation training | 0.760988 |
| tobacco cessation community | 0.775835 |
| health care | 0.871852 |
| treatment protocols | 0.722655 |
| health care systems | 0.709262 |
| three-part treatment guidance | 0.683725 |
| cardiovascular disease | 0.732003 |
| electronic health records | 0.712409 |
| primary care | 0.739924 |
| available evidence-based protocols | 0.715185 |
| Tobacco Control Initiative | 0.743318 |
| High low-density lipoprotein | 0.675654 |
|
CLICK HERE |